Respiratory syncytial virus and pulmonary delivery biology essay
Pulmonary administration of nucleic acids may be particularly relevant for the treatment of localized lung diseases of genetic origin.1 The pulmonary route would also be suitable for the administration of inhaled DNA vaccines as it would follow the natural route of infection for common airborne transmitted diseases,3 Such as measles, Respiratory Syncytial Virus, Respiratory tract inflammation and deterioration in patients with chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine, Respiratory syncytial virus RSV causes infections of the lungs and respiratory tract. It is so common that most children have already been infected with the virus. Respiratory syncytial sin-SISH-ul virus can also infect adults. In adults and older, healthy children, RSV symptoms are mild and usually resemble a cold. Introduction. Respiratory syncytial virus RSV is classified in the Pneumovirus genus of the Paramyxoviridae family, an enveloped virus with a single-stranded negative-sense RNA genome. in length encoding subgenomic mRNA proteins. RSV is the leading cause of acute respiratory syncytial virus worldwide. RSV is one of the leading causes of viral respiratory infections in infants, the elderly, and the immunocompromised worldwide, causing more deaths annually than influenza. Years of research into RSV since its discovery a year ago have elucidated detailed mechanisms of the host pathogen,